Trial Profile
A review of reports of lymphoma occurring in patients with rheumatoid arthritis or Crohn's disease in Centocor-sponsored and Centocor-supported disease registries
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2014
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Crohn's disease; Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Centocor
- 22 Oct 2007 Status changed from in progress to completed.
- 05 Apr 2007 New trial record.